tci Part B Insider - 2021 Issue Q3

Physician Notes: See New Reimbursement Details on COVID-19 Infusions

You can expect a little more money in your pocket when you administer monoclonal antibody infusions to Medicare beneficiaries with COVID-19, says the Centers for Medicare & Medicaid Services (CMS) in a May 6 release on the change. Now: Nationally, the average payment will go up from $310 to $450 in most healthcare locales, CMS indicates. The agency also plans to “establish a higher national payment rate of $750 when monoclonal antibodies are administered in the beneficiary’s home, including the beneficiary’s permanent residence or temporary lodging (e.g., hotel/motel, cruise ship, hostel, or homeless shelter),&rdquo...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.